Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage

Non-small cell lung cancer (NSCLC) poses a significant global health burden with unsatisfactory survival rates, despite advancements in diagnostic and therapeutic modalities. Novel therapeutic approaches are urgently required to improve patient outcomes. Pharmacological ascorbate (P-AscH<sup>−...

Full description

Bibliographic Details
Main Authors: Kittipong Sanookpan, Naphat Chantaravisoot, Nuttiya Kalpongnukul, Chatchapon Chuenjit, Onsurang Wattanathamsan, Sara Shoaib, Pithi Chanvorachote, Visarut Buranasudja
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/12/9/1775
_version_ 1797581497594544128
author Kittipong Sanookpan
Naphat Chantaravisoot
Nuttiya Kalpongnukul
Chatchapon Chuenjit
Onsurang Wattanathamsan
Sara Shoaib
Pithi Chanvorachote
Visarut Buranasudja
author_facet Kittipong Sanookpan
Naphat Chantaravisoot
Nuttiya Kalpongnukul
Chatchapon Chuenjit
Onsurang Wattanathamsan
Sara Shoaib
Pithi Chanvorachote
Visarut Buranasudja
author_sort Kittipong Sanookpan
collection DOAJ
description Non-small cell lung cancer (NSCLC) poses a significant global health burden with unsatisfactory survival rates, despite advancements in diagnostic and therapeutic modalities. Novel therapeutic approaches are urgently required to improve patient outcomes. Pharmacological ascorbate (P-AscH<sup>−</sup>; ascorbate at millimolar concentration in plasma) emerged as a potential candidate for cancer therapy for recent decades. In this present study, we explore the anti-cancer effects of P-AscH<sup>−</sup> on NSCLC and elucidate its underlying mechanisms. P-AscH<sup>−</sup> treatment induces formation of cellular oxidative distress; disrupts cellular bioenergetics; and leads to induction of apoptotic cell death and ultimately reduction in clonogenic survival. Remarkably, DNA and DNA damage response machineries are identified as vulnerable targets for P-AscH<sup>−</sup> in NSCLC therapy. Treatments with P-AscH<sup>−</sup> increase the formation of DNA damage and replication stress markers while inducing mislocalization of DNA repair machineries. The cytotoxic and genotoxic effects of P-AscH<sup>−</sup> on NSCLC were reversed by co-treatment with catalase, highlighting the roles of extracellular hydrogen peroxide in anti-cancer activities of P-AscH<sup>−</sup>. The data from this current research advance our understanding of P-AscH<sup>−</sup> in cancer treatment and support its potential clinical use as a therapeutic option for NSCLC therapy.
first_indexed 2024-03-10T23:05:23Z
format Article
id doaj.art-55ca4bda1546477cb501b23c98f5bcae
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T23:05:23Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-55ca4bda1546477cb501b23c98f5bcae2023-11-19T09:20:18ZengMDPI AGAntioxidants2076-39212023-09-01129177510.3390/antiox12091775Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-DamageKittipong Sanookpan0Naphat Chantaravisoot1Nuttiya Kalpongnukul2Chatchapon Chuenjit3Onsurang Wattanathamsan4Sara Shoaib5Pithi Chanvorachote6Visarut Buranasudja7Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandDepartment of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, ThailandCenter of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, ThailandDepartment of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, ThailandDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, ThailandNon-small cell lung cancer (NSCLC) poses a significant global health burden with unsatisfactory survival rates, despite advancements in diagnostic and therapeutic modalities. Novel therapeutic approaches are urgently required to improve patient outcomes. Pharmacological ascorbate (P-AscH<sup>−</sup>; ascorbate at millimolar concentration in plasma) emerged as a potential candidate for cancer therapy for recent decades. In this present study, we explore the anti-cancer effects of P-AscH<sup>−</sup> on NSCLC and elucidate its underlying mechanisms. P-AscH<sup>−</sup> treatment induces formation of cellular oxidative distress; disrupts cellular bioenergetics; and leads to induction of apoptotic cell death and ultimately reduction in clonogenic survival. Remarkably, DNA and DNA damage response machineries are identified as vulnerable targets for P-AscH<sup>−</sup> in NSCLC therapy. Treatments with P-AscH<sup>−</sup> increase the formation of DNA damage and replication stress markers while inducing mislocalization of DNA repair machineries. The cytotoxic and genotoxic effects of P-AscH<sup>−</sup> on NSCLC were reversed by co-treatment with catalase, highlighting the roles of extracellular hydrogen peroxide in anti-cancer activities of P-AscH<sup>−</sup>. The data from this current research advance our understanding of P-AscH<sup>−</sup> in cancer treatment and support its potential clinical use as a therapeutic option for NSCLC therapy.https://www.mdpi.com/2076-3921/12/9/1775pharmacological ascorbateanti-cancernon-small cell lung cancerDNA damagepro-oxidantadjuvant
spellingShingle Kittipong Sanookpan
Naphat Chantaravisoot
Nuttiya Kalpongnukul
Chatchapon Chuenjit
Onsurang Wattanathamsan
Sara Shoaib
Pithi Chanvorachote
Visarut Buranasudja
Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage
Antioxidants
pharmacological ascorbate
anti-cancer
non-small cell lung cancer
DNA damage
pro-oxidant
adjuvant
title Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage
title_full Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage
title_fullStr Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage
title_full_unstemmed Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage
title_short Pharmacological Ascorbate Elicits Anti-Cancer Activities against Non-Small Cell Lung Cancer through Hydrogen-Peroxide-Induced-DNA-Damage
title_sort pharmacological ascorbate elicits anti cancer activities against non small cell lung cancer through hydrogen peroxide induced dna damage
topic pharmacological ascorbate
anti-cancer
non-small cell lung cancer
DNA damage
pro-oxidant
adjuvant
url https://www.mdpi.com/2076-3921/12/9/1775
work_keys_str_mv AT kittipongsanookpan pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage
AT naphatchantaravisoot pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage
AT nuttiyakalpongnukul pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage
AT chatchaponchuenjit pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage
AT onsurangwattanathamsan pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage
AT sarashoaib pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage
AT pithichanvorachote pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage
AT visarutburanasudja pharmacologicalascorbateelicitsanticanceractivitiesagainstnonsmallcelllungcancerthroughhydrogenperoxideinduceddnadamage